September 1, 2025

Globus Medical, Inc. (GMED) Stock Analysis: Evaluating a 34.72% Potential Upside in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a titan in the healthcare sector specializing in innovative medical devices, has garnered significant investor interest due to its robust potential..

Masimo Corporation (MASI) Stock Analysis: Exploring a 34% Potential Upside in the Healthcare Sector

Masimo Corporation (MASI), a prominent player in the medical devices industry, is capturing investor attention with a compelling potential upside of 34.26%. As the healthcare sector..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating a 23.78% Potential Upside with Strong Buy Ratings

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has carved out a significant niche in the biotechnology sector, with a robust portfolio of innovative treatments addressing a wide array..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unraveling a 67.52% Potential Upside for Investors

For investors seeking promising opportunities in the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents a tantalizing prospect. With a market capitalization of $11.19 billion and..

West Pharmaceutical Services (WST) Investor Outlook: Analyzing the 28.11% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a stalwart in the healthcare sector, specifically within the Medical Instruments & Supplies industry. As the company approaches..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 20% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) stands as a unique player within the biotechnology industry, specializing as a major buyer of biopharmaceutical royalties and a strategic funder..

Tempus AI, Inc. (TEM) Stock Analysis: Evaluating Growth Potential and Analyst Sentiments

Tempus AI, Inc. (NASDAQ: TEM) is a burgeoning player within the healthcare sector, specializing in health information services. With a market capitalization of $13.18 billion, Tempus..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Closer Look at Its 89% Return on Equity and Market Performance

Medpace Holdings, Inc. (NASDAQ: MEDP) is a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $13.36..

Gilead Sciences, Inc. (GILD) Stock Analysis: 10% Upside Potential with Robust Pipeline and Strong Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD), a leader in the biopharmaceutical industry, is capturing considerable attention from investors due to its promising upside potential and strong dividend..

Bristol-Myers Squibb (BMY) Stock Analysis: Unlocking a 12.34% Potential Upside in the Healthcare Sector

Bristol-Myers Squibb Company (NYSE: BMY) stands as a cornerstone in the healthcare sector, offering a diverse array of biopharmaceutical products that cater to various therapeutic areas...

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 23% Upside Potential with Strong Buy Ratings

AptarGroup, Inc. (NYSE: ATR), a leader in the healthcare sector specializing in medical instruments and supplies, is catching the attention of investors due to a promising..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating High ROE and Analyst Consensus

HCA Healthcare, Inc. (NYSE: HCA), a stalwart in the medical care facilities sector, operates a vast network of hospitals and related healthcare entities across the United..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 25.83% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing attention from investors..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a Potential 18.81% Upside

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, is drawing attention with a potential upside of 18.81% based on the average target..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 6.93% Potential Upside in a Dynamic Healthcare Market

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) is making waves in the pharmaceutical industry, capturing investor attention with a potential upside of 6.93%. With its operations spanning..

Stryker Corporation (SYK) Stock Analysis: Strong Growth Potential with 10.44% Upside

Stryker Corporation (NYSE: SYK) continues to reinforce its position as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market..

Quest Diagnostics Incorporated (DGX)

⚠️ No article content returned.

..

Centene Corporation (CNC) Stock Analysis: Exploring a 20% Upside Potential

Centene Corporation (NYSE: CNC), a prominent player in the Healthcare Plans industry, has piqued investor interest with its potential upside of 20.09% based on current analyst..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant with 14% Upside Potential

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a..

ICON plc (ICLR) Stock Analysis: Exploring a 21.84% Potential Upside in the Healthcare Sector

ICON plc (ICLR), a leading player in the healthcare sector, particularly in diagnostics and research, is drawing significant attention from investors. Based in Dublin, Ireland, ICON..

Search

Funds

September 1, 2025

Search

Funds

September 1, 2025

FTSE 100

Funds